During the past decade, Tennessee Valley Healthcare System Nashville Campus, Nashville, TN conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" #1 sponsor was "VA Office of Research and Development" with 25 trials, followed by "Eastern Cooperative Oncology Group" with 8 trials sponsored, "Centers for Disease Control and Prevention" with 4 trials sponsored, "US Department of Veterans Affairs" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Vanderbilt University Medical Center" with 3 trials as a collaborator, "American College of Radiology Imaging Network" with 1 trials as a collaborator, "American Society of Health-System Pharmacists Research and Education Foundation" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" are "Lung Cancer" (4 trials), "Cardiovascular Disease" (3 trials), "Colorectal Cancer" (3 trials), "Obesity" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" in a lesser frequency.

Most popular intervention types in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" are "Drug" (31 trials), "Other" (16 trials), "Procedure" (10 trials), "Behavioral" (8 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "conventional surgery" (2 trials), "fluorouracil" (2 trials), "radiation therapy" (2 trials) and "surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN" are 53 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 11 active trials in "Tennessee Valley Healthcare System Nashville Campus, Nashville, TN". 1 are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 19 trials that are defined as “Not Applicable".